Michele P Lambert, MD, MTR
Associate Professor of Pediatrics (Hematology) at the Children's Hospital of Philadelphia
Attending Physician, Division of Hematology, Children's Hospital of Philadelphia
Consulting Attending Physician, Section of Hematology/Oncology, Pennsylvania Hospital
Consulting Physician, Section of Newborn Pediatrics, Hospital of the University of Pennsylvania
Medical Director, Special Coagulation Laboratory, Department of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia
Co-Director, Frontier Program in Immune Dysregulation, Children's Hospital of Philadelphia
Director, Pediatric Platelet Disorder Program, Division of Hematology, Children's Hospital of Philadelphia
Department: Pediatrics
Contact information
Children's Hospital of Philadelphia
Division of Hematology
3615 Civic Center Blvd
Philadelphia, PA 19083
Division of Hematology
3615 Civic Center Blvd
Philadelphia, PA 19083
Office: 215-590-4667
Fax: 267-426-5476
Lab: 215-590-1971
Fax: 267-426-5476
Lab: 215-590-1971
Email:
lambertm@email.chop.edu
lambertm@email.chop.edu
Education:
BS (Biology)
Rensselaer Polytechnic Institute, 1995.
MD
UMDNJ - New Jersey Medical School, 1999.
MTR (Translational Research)
University of Pennsylvania School of Medicine, 2010.
Permanent linkBS (Biology)
Rensselaer Polytechnic Institute, 1995.
MD
UMDNJ - New Jersey Medical School, 1999.
MTR (Translational Research)
University of Pennsylvania School of Medicine, 2010.
Selected Publications
Al-Huniti A, Haley K, Sarode R, Lambert MP, Zia A, Doshi BS: PB0986 - Systematic review on the management of hemostatic defects in children with liver disease. ISTH Meeting 2025, Washington, DC (Poster) June 2025.Doshi BS, Lambert MP, Haley KF, Sarode R, Al-Hunti A, Zia A: PB0985 - Systematic review on the diagnosis of hemostatic defects in children with liver disease. ISTH Meeting 2025, Washington, DC (Poster) June 2025.
Grace, RF, Leblebisatan G, Aydinok Y, Ünal S, Grainger G, Grimes A, Lambert M, Zhang J, Jamieson B, Vredenburg M, Kolodny S: PB0364 - Evaluation of Efficacy and Safety of Avatrombopag in Children with ITP Based on Disease Duration. ISTH Meeting 2025, Washington, DC (poster) June 2025.
Grace RF, Leblesbisatan G, Aydinok Y, Unal S, Grainger J, Grimes A, Lambert MP, Zhang J, Jameson B, Vredenburg M, Kolodny S: PB0348 - Consistent Response to Avatrombopag for Pediatric ITP Across Various Baseline Characteristics. ISTH Meeting 2025, Washington, DC (Poster) June 2025.
O'Farrell C, Grimes AB, Nakano TA, Klaassen RJ, Lambert MP, Neunert CE, Rothman JA, Shimano KA, Grace RF.: International Consensus in Aiming to Define "Refractory ITP" Blood Adv 9(11): 1244-1245, Mar 2025.
Del Carpio-Cano F, Songdej N, Guan L, Mao G, Goldfinger LE, Wurtzel JGT, Lee K, Lambert MP, Poncz M, Rao AK.: Transcription factor RUNX1 regulates coagulation factor XIII-A (F13A1): decreased platelet-megakaryocyte F13A1 expression and clot contraction in RUNX1 haplodeficiency. Res Pract Thromb Haemost 9(1): 102680, Jan 2025.
Crowley TB, Campbell I, Arulselvan A, Friedman D, Zackai EH, Geoffrion TR, Witmer C, Gaynor JW, McDonald-McGinn DM, Lambert MP.: A case-control study of bleeding risk in children with 22q11.2 deletion syndrome undergoing cardiac surgery. Platelets 35(1): 2290108, December 2024.
Lambert MP.: On the horizon: upcoming new agents for the management of ITP. Hematology Am Soc Hematol Educ Program 2024(1): 692-699, Dec 2024.
Del Carpio-Cano F, Songdej N, Guan L, Mao G, Goldfinger LE, Wurtzel JGT, Lee K, Lambert MP, Poncz M, Koneti Rao A.: Transcription Factor RUNX1 Regulates Coagulation Factor XIII-A ( F13A1 ): Decreased Platelet-Megakaryocyte F13A1 Expression and Clot Contraction in RUNX1 Haplodeficiency. medRxiv Page: doi: 10.1101/2024.12.17.24318561, Dec 2024.
Lambert MP, Warkentin TE.: Mini-clusters of postadenovirus VITT. Res Pract Thromb Haemost 9(1): 102641, November 2024.